2016 discharge: EMCDDA

This procedure concerns the formal approval of the 2016 budget execution for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The European Parliament reviews how the agency managed its funds to ensure they were spent legally, efficiently, and in accordance with EU financial regulations.

This decision affects the EMCDDA's administration and financial management. A positive discharge confirms that the agency's accounts are accurate and its spending is justified.